DD Revocable Trust - 06 Feb 2026 Form 3 Insider Report for Xerox Holdings Corp (XRX)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
08 Apr 2026, 09:47:17 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Douglas R. Deason, Executor of the DD Revocable Trust

Key filing fact

DD Revocable Trust filed Form 3 for Xerox Holdings Corp (XRX) on 08 Apr 2026.

Key facts

  • This page summarizes DD Revocable Trust's Form 3 filing for Xerox Holdings Corp (XRX).
  • 0 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 08 Apr 2026, 09:47.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002127518 Primary reporting owner

DD Revocable Trust

Relationship
10%+ Owner
Address
3953 MAPLE AVE, SUITE 150, DALLAS
Signature
/s/ Douglas R. Deason, Executor of the DD Revocable Trust
Signature date
07 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XRX holding

Common Stock, $1.00 par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
8,542,096
Date
06 Feb 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XRX holding Derivative

Series A Convertible Perpetual Voting Preferred Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
06 Feb 2026
Ownership
Direct
Underlying class
6,741,576 Shares of Common Stock
Underlying amount
180,000
Exercise price
Footnotes
F1
XRX holding Derivative

Warrants to Purchase Shares of Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
06 Feb 2026
Ownership
Direct
Underlying class
7,641,828 Shares of Common Stock
Underlying amount
7,641,828
Exercise price
$8.00
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each share of Series A Convertible Perpetual Voting Preferred Stock ("Series A Preferred Stock") is convertible into shares of common stock (the "Shares") at a conversion rate of approximately 37.4532 Shares per share of Series A Preferred Stock, subject to adjustment.

Footnote F2

The Trust holds warrants to purchase shares of Common Stock (the "Warrants") distributed by the Issuer on February 12, 2026, at a ratio of one Warrant for every two Shares held as of the record date. Each Warrant entitles the holder to purchase one Share at an exercise price of $8.00 per Warrant subject to the Issuer's right to voluntarily decrease such exercise price in its sole and absolute discretion from time to time. The Warrants are expected to expire and cease to be exercisable on February 11, 2028, unless certain conditions are met for an earlier expiration date.

SEC remarks

This Form 3 is being filed by the DD Revocable Trust (the "Trust") in connection with its initial reporting obligation under Section 16(a) of the Securities Exchange Act of 1934, as amended. Following the passing of Darwin Deason on December 2, 2025, the Trust became irrevocable by operation of law. The Trust is the successor in interest to the shares previously beneficially owned by Darwin Deason. On February 6, 2026, the appropriate court issued Letters Testamentary appointing Douglas R. Deason, Scott Letier, and Bryan C. Birkland as Co-Executors of the Trust.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .